{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:49:31Z","timestamp":1794962971719,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Herzzentrum G\u00f6ttingen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Significant bleeding of tumor sites is a dreaded complication in oncological diseases and often results in clinical emergencies. Besides basic local and interventional procedures, an urgent radiotherapeutic approach can either achieve a bleeding reduction or a bleeding stop in a vast majority of patients. In spite of being used regularly in clinical practice, data reporting results to this therapy approach is still scarce.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively analyzed 77 patients treated for significant tumor-related bleeding at our clinic between 2000 and 2021, evaluating treatment response rate, hemoglobin levels, hemoglobin transfusion necessity, administered radiotherapy dose and overall survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Response rate in terms of bleeding stop was 88.3% (68\/77) in all patients and 95.2% (60\/63) in the subgroup, wherein radiotherapy (RT) was completed as intended. Hemoglobin transfusions decreased during treatment in a further subgroup analysis. Median overall survival (OS) was 3.3 months. Patients with primary tumors (PT) of the cervix (carcinoma of the cervix, CC) or endometrium (endometrioid carcinoma, EDC) and patients receiving the full intended RT dose showed statistically significant better OS in a multivariable cox regression model. Median administered dose was 39 Gy, treatment related acute toxicity was considerably low.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our data show an excellent response rate with a low toxicity profile when administering urgent radiotherapy for tumor related clinically significant bleeding complications. Nonetheless, treatment decisions should be highly individual due to the low median overall survival of this patient group.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-023-02391-5","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T17:02:24Z","timestamp":1703091744000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hemostatic radiotherapy in clinically significant tumor-related bleeding: excellent palliative results in a retrospective analysis of 77 patients"],"prefix":"10.1186","volume":"18","author":[{"given":"Manuel","family":"Guhlich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Esther","family":"Maag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif Hendrik","family":"Dr\u00f6ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Hille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Donath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Bendrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus Anton","family":"Schirmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Nauck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Leu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Riggert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Gallwas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Rieken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"issue":"5","key":"2391_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1634\/theoncologist.9-5-561","volume":"9","author":"J Pereira","year":"2004","unstructured":"Pereira J, Phan T. Management of bleeding in patients with advanced cancer. Oncologist. 2004;9(5):561\u201370.","journal-title":"Oncologist"},{"issue":"2","key":"2391_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.21037\/apm.2017.11.01","volume":"7","author":"C Johnstone","year":"2018","unstructured":"Johnstone C, Rich SE. Bleeding in cancer patients and its treatment: a review. Ann Palliat Med. 2018;7(2):265\u201373.","journal-title":"Ann Palliat Med"},{"key":"2391_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.conctc.2018.05.015","volume":"11","author":"KL Margolis","year":"2018","unstructured":"Margolis KL, Mahady SE, Nelson MR, Ives DG, Satterfield S, Britt C, et al. Development of a standardized definition for clinically significant bleeding in the ASPirin in Reducing Events in the Elderly (ASPREE) trial. Contemp Clin Trials Commun. 2018;11:30\u20136.","journal-title":"Contemp Clin Trials Commun"},{"key":"2391_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1748-717X-7-132","volume":"7","author":"N Cihoric","year":"2012","unstructured":"Cihoric N, Crowe S, Eychm\u00fcller S, Aebersold DM, Ghadjar P. Clinically significant bleeding in incurable cancer patients: effectiveness of hemostatic radiotherapy. Radiat Oncol. 2012;7:132.","journal-title":"Radiat Oncol"},{"issue":"3","key":"2391_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/10245330500093237","volume":"10","author":"E Prommer","year":"2005","unstructured":"Prommer E. Management of bleeding in the terminally ill patient. Hematology. 2005;10(3):167\u201375.","journal-title":"Hematology"},{"issue":"11","key":"2391_CR6","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1470-2045(08)70278-X","volume":"9","author":"F Nauck","year":"2008","unstructured":"Nauck F, Alt-Epping B. Crises in palliative care\u2014a comprehensive approach. Lancet Oncol. 2008;9(11):1086\u201391.","journal-title":"Lancet Oncol"},{"issue":"Suppl 1","key":"2391_CR7","first-page":"38","volume":"25","author":"N Thosani","year":"2014","unstructured":"Thosani N, Rao B, Ghouri Y, Batra S, Raju G, Shafi M, et al. Role of argon plasma coagulation in management of bleeding GI tumors: evaluating outcomes and survival. Turk J Gastroenterol. 2014;25(Suppl 1):38\u201342.","journal-title":"Turk J Gastroenterol"},{"issue":"5","key":"2391_CR8","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.juro.2010.01.003","volume":"183","author":"A Delgal","year":"2010","unstructured":"Delgal A, Cercueil J-P, Koutlidis N, Michel F, Kermarrec I, Mourey E, et al. Outcome of transcatheter arterial embolization for bladder and prostate hemorrhage. J Urol. 2010;183(5):1947\u201353.","journal-title":"J Urol"},{"key":"2391_CR9","doi-asserted-by":"crossref","unstructured":"Carson JL, Stanworth SJ, Dennis JA, Trivella M, Roubinian N, Fergusson DA, et al. Transfusion thresholds for guiding red blood cell transfusion. Cochrane Database Syst Rev. 2021;12:CD002042.","DOI":"10.1002\/14651858.CD002042.pub5"},{"issue":"11","key":"2391_CR10","volume":"13","author":"A Katano","year":"2021","unstructured":"Katano A, Yamashita H. The efficacy of hemostatic radiotherapy for advanced malignancies assessed by World Health Organization Bleeding Status. Cureus. 2021;13(11): e19939.","journal-title":"Cureus"},{"issue":"6","key":"2391_CR11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4103\/0970-258X.303621","volume":"32","author":"P Kumar","year":"2019","unstructured":"Kumar P, Rastogi K, Dana R, Rakesh A, Bairwa SC, Bhaskar S. Tumour bleeding: efficacy and outcome of haemostatic radiotherapy. Natl Med J India. 2019;32(6):342\u20134.","journal-title":"Natl Med J India"},{"issue":"6","key":"2391_CR12","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1590\/S1677-5538.IBJU.2013.06.06","volume":"39","author":"E Lacarri\u00e8re","year":"2013","unstructured":"Lacarri\u00e8re E, Smaali C, Benyoucef A, Pfister C, Grise P. The efficacy of hemostatic radiotherapy for bladder cancer-related hematuria in patients unfit for surgery. Int Braz J Urol. 2013;39(6):808\u201316.","journal-title":"Int Braz J Urol"},{"issue":"2","key":"2391_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.2307\/3578813","volume":"137","author":"M Verheij","year":"1994","unstructured":"Verheij M, Dewit LGH, Boomgaard MN, Brinkman H-JM, van Mourik JA. Ionizing radiation enhances platelet adhesion to the extracellular matrix of human endothelial cells by an increase in the release of von Willebrand Factor. Radiat Res. 1994;137(2):202.","journal-title":"Radiat Res"},{"issue":"1","key":"2391_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.radonc.2010.09.002","volume":"97","author":"J Yarnold","year":"2010","unstructured":"Yarnold J, Brotons M-CV. Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol. 2010;97(1):149\u201361.","journal-title":"Radiother Oncol"},{"issue":"9","key":"2391_CR15","doi-asserted-by":"publisher","first-page":"e478","DOI":"10.1016\/j.clon.2023.06.007","volume":"35","author":"J Song","year":"2023","unstructured":"Song J, Brown C, Dennis K, Gaudet M, Haddad A. Palliative radiotherapy for haemostasis in malignancy: a systematic review. Clin Oncol. 2023;35(9):e478\u201388.","journal-title":"Clin Oncol"},{"issue":"3","key":"2391_CR16","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0360-3016(00)00446-6","volume":"47","author":"C Faul","year":"2000","unstructured":"Faul C, Gerszten K, Edwards R, Land S, D\u2019Angelo G, Kelley J, et al. A phase I\/II study of hypofractionated whole abdominal radiation therapy in patients with chemoresistant ovarian carcinoma: Karnofsky score determines treatment outcome. Int J Radiat Oncol Biol Phys. 2000;47(3):749\u201354.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2391_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0360-3016(79)91212-4","volume":"5","author":"RJ Boulware","year":"1979","unstructured":"Boulware RJ, Caderao JB, Delclos L, Wharton JT, Peters LJ. Whole pelvis megavoltage irradiation with single doses of 1000 rad to palliate advanced gynecologic cancers. Int J Radiat Oncol Biol Phys. 1979;5(3):333\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"2391_CR18","first-page":"633","volume":"13","author":"N Begum","year":"2003","unstructured":"Begum N, Asghar AH, Khan SM, Khan A. High dose rate intraluminal brachytherapy in combination with external beam radiotherapy for palliative treatment of cancer rectum. J Coll Phys Surg Pak. 2003;13(11):633\u20136.","journal-title":"J Coll Phys Surg Pak"},{"issue":"4","key":"2391_CR19","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.ijrobp.2016.03.010","volume":"95","author":"V Picardi","year":"2016","unstructured":"Picardi V, Deodato F, Guido A, Giaccherini L, Macchia G, Frazzoni L, et al. Palliative short-course radiation therapy in rectal cancer: a phase 2 study. Int J Radiat Oncol Biol Phys. 2016;95(4):1184\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2391_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.radonc.2016.06.023","volume":"121","author":"D Chia","year":"2016","unstructured":"Chia D, Lu J, Zheng H, Loy E, Lim K, Leong C, et al. Efficacy of palliative radiation therapy for symptomatic rectal cancer. Radiother Oncol. 2016;121(2):258\u201361.","journal-title":"Radiother Oncol"},{"key":"2391_CR21","doi-asserted-by":"crossref","unstructured":"Report to the Medical Research Council by its Lung Cancer Working Party. Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Br J Cancer. 1991;63(2):265\u201370.","DOI":"10.1038\/bjc.1991.62"},{"issue":"2\u20133","key":"2391_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0169-5002(96)00630-7","volume":"16","author":"D Ornadel","year":"1997","unstructured":"Ornadel D, Duchesne G, Wall P, Ng A, Hetzel M. Defining the roles of high dose rate endobronchial brachytherapy and laser resection for recurrent bronchial malignancy. Lung Cancer. 1997;16(2\u20133):203\u201313.","journal-title":"Lung Cancer"},{"issue":"2","key":"2391_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0936-6555(05)80446-7","volume":"9","author":"GJ Rees","year":"1997","unstructured":"Rees GJ, Devrell CE, Barley VL, Newman HF. Palliative radiotherapy for lung cancer: two versus five fractions. Clin Oncol. 1997;9(2):90\u20135.","journal-title":"Clin Oncol"},{"issue":"4","key":"2391_CR24","first-page":"148","volume":"37","author":"ML Bhatt","year":"2000","unstructured":"Bhatt ML, Mohani BK, Kumar L, Chawla S, Sharma DN, Rath GK. Palliative treatment of advanced non small cell lung cancer with weekly fraction radiotherapy. Indian J Cancer. 2000;37(4):148\u201352.","journal-title":"Indian J Cancer"},{"issue":"1","key":"2391_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0360-3016(99)00540-4","volume":"47","author":"JA Langendijk","year":"2000","unstructured":"Langendijk JA, ten Velde GP, Aaronson NK, de Jong JM, Muller MJ, Wouters EF. Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys. 2000;47(1):149\u201355.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2391_CR26","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1183\/09031936.04.00114902","volume":"24","author":"JA Escobar-Sacrist\u00e1n","year":"2004","unstructured":"Escobar-Sacrist\u00e1n JA, Granda-Orive JI, Guti\u00e9rrez Jim\u00e9nez T, Delgado JM, Rodero Ba\u00f1os A, Saez VR. Endobronchial brachytherapy in the treatment of malignant lung tumours. Eur Respir J. 2004;24(3):348\u201352.","journal-title":"Eur Respir J"},{"issue":"3","key":"2391_CR27","first-page":"128","volume":"67","author":"A Scarda","year":"2007","unstructured":"Scarda A, Confalonieri M, Baghiris C, Binato S, Mazzarotto R, Palamidese A, et al. Out-patient high-dose-rate endobronchial brachytherapy for palliation of lung cancer: an observational study. Monaldi Arch Chest Dis. 2007;67(3):128\u201334.","journal-title":"Monaldi Arch Chest Dis"},{"issue":"6","key":"2391_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038960","volume":"7","author":"A Gross","year":"2012","unstructured":"Gross A, Ziepert M, Scholz M. KMWin\u2013a convenient tool for graphical presentation of results from Kaplan\u2013Meier survival time analysis. PLoS ONE. 2012;7(6): e38960.","journal-title":"PLoS ONE"},{"key":"2391_CR29","unstructured":"U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Common Terminology Criteria for Adverse Evens (CTCAE), Version 5.0; 2017 [cited 2021 Nov 23]. https:\/\/www.eortc.be\/services\/doc\/ctc\/CTCAE_v5_Quick_Reference_5x7.pdf."},{"key":"2391_CR30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13014-019-1242-z","volume":"14","author":"LG Sapienza","year":"2019","unstructured":"Sapienza LG, Ning MS, Jhingran A, Lin LL, Le\u00e3o CR, da Silva BB, et al. Short-course palliative radiation therapy leads to excellent bleeding control: a single centre retrospective study. Clin Transl Radiat Oncol. 2019;14:40\u20136.","journal-title":"Clin Transl Radiat Oncol"},{"issue":"11","key":"2391_CR31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.14312\/2052-4994.2015-18","volume":"3","author":"S Nomoto","year":"2015","unstructured":"Nomoto S, Akai T, Nomiyama H, Kuwano H, Kuwabara Y, Yoshimitsu K. A retrospective study of the effectiveness of hemostatic radiotherapy with conventional fractionation in patients with advanced cancer. J Cancer Res Ther. 2015;3(11):124\u20138.","journal-title":"J Cancer Res Ther"},{"issue":"2","key":"2391_CR32","volume":"10","author":"M Shuja","year":"2018","unstructured":"Shuja M, Nazli S, Mansha MA, Iqbal A, Mohamed R, Tunio MA, et al. Bleeding in locally invasive pelvic malignancies: is hypofractionated radiation therapy a safe and effective non-invasive option for securing hemostasis? A single institution perspective. Cureus. 2018;10(2): e2137.","journal-title":"Cureus"},{"issue":"6","key":"2391_CR33","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.21873\/invivo.11718","volume":"33","author":"J Tey","year":"2019","unstructured":"Tey J, Soon YY, Cheo T, Ooi KH, Ho F, Vellayappan B, et al. Efficacy of palliative bladder radiotherapy for hematuria in advanced bladder cancer using contemporary radiotherapy techniques. In Vivo. 2019;33(6):2161\u20137.","journal-title":"In Vivo"},{"issue":"1","key":"2391_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1089\/pmr.2020.0027","volume":"1","author":"H Zhang","year":"2020","unstructured":"Zhang H, Hojo H, Parshuram Raturi V, Nakamura N, Nakamura M, Okumura M, et al. Palliative radiation therapy for macroscopic hematuria caused by urothelial cancer. Palliat Med Rep. 2020;1(1):201\u20137.","journal-title":"Palliat Med Rep"},{"issue":"1111","key":"2391_CR35","doi-asserted-by":"publisher","first-page":"20190958","DOI":"10.1259\/bjr.20190958","volume":"93","author":"O Tanaka","year":"2020","unstructured":"Tanaka O, Sugiyama A, Omatsu T, Tawada M, Makita C, Matsuo M. Hemostatic radiotherapy for inoperable gastric cancer: a pilot study. Br J Radiol. 2020;93(1111):20190958.","journal-title":"Br J Radiol"},{"issue":"1","key":"2391_CR36","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/s12885-021-08145-4","volume":"21","author":"J Yu","year":"2021","unstructured":"Yu J, Jung J, Park SR, Ryu M-H, Park J-H, Kim JH, et al. Role of palliative radiotherapy in bleeding control in patients with unresectable advanced gastric cancer. BMC Cancer. 2021;21(1):413.","journal-title":"BMC Cancer"},{"key":"2391_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12904-015-0034-y","volume":"14","author":"C Kondoh","year":"2015","unstructured":"Kondoh C, Shitara K, Nomura M, Takahari D, Ura T, Tachibana H, et al. Efficacy of palliative radiotherapy for gastric bleeding in patients with unresectable advanced gastric cancer: a retrospective cohort study. BMC Palliat Care. 2015;14:37.","journal-title":"BMC Palliat Care"},{"issue":"1","key":"2391_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13014-021-01884-5","volume":"16","author":"J Lee","year":"2021","unstructured":"Lee J, Byun HK, Koom WS, Lee YC, Seong J. Efficacy of radiotherapy for gastric bleeding associated with advanced gastric cancer. Radiat Oncol. 2021;16(1):161.","journal-title":"Radiat Oncol"},{"issue":"1","key":"2391_CR39","doi-asserted-by":"publisher","first-page":"9533","DOI":"10.1038\/s41598-021-88952-8","volume":"11","author":"M Ogita","year":"2021","unstructured":"Ogita M, Kawamori J, Yamashita H, Nakagawa K. Palliative radiotherapy for gross hematuria in patients with advanced cancer. Sci Rep. 2021;11(1):9533.","journal-title":"Sci Rep"},{"issue":"2","key":"2391_CR40","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jpainsymman.2020.08.011","volume":"61","author":"AA Butala","year":"2021","unstructured":"Butala AA, Lee DY, Patel RR, Latif NA, Haggerty AF, Paydar I, et al. A retrospective study of rapid symptom response in bleeding gynecologic malignancies with short course palliative radiation therapy: less is more. J Pain Symp Manag. 2021;61(2):377-383.e2.","journal-title":"J Pain Symp Manag"},{"issue":"6","key":"2391_CR41","doi-asserted-by":"publisher","first-page":"e439","DOI":"10.1016\/j.prro.2017.03.007","volume":"7","author":"M Krishnan","year":"2017","unstructured":"Krishnan M, Racsa M, Jones J, Chittenden E, Schaefer KG, Spektor A, et al. Radiation oncology resident palliative education. Pract Radiat Oncol. 2017;7(6):e439\u201348.","journal-title":"Pract Radiat Oncol"},{"issue":"3","key":"2391_CR42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00066-022-01989-0","volume":"199","author":"M Oertel","year":"2023","unstructured":"Oertel M, Schmidt R, Steike DR, Eich HT, Lenz P. Palliative care on the radiation oncology ward-improvements in clinical care through interdisciplinary ward rounds. Strahlenther Onkol. 2023;199(3):251\u20137.","journal-title":"Strahlenther Onkol"},{"issue":"6","key":"2391_CR43","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.rpor.2020.09.007","volume":"25","author":"G Lo Presti","year":"2020","unstructured":"Lo Presti G, Roncador M, Biggiogero M, Soloni C, Franzetti-Pellanda A. Radiation oncologists role, training and perceptions in palliative care: a systematic review. Rep Pract Oncol Radiother. 2020;25(6):939\u201342.","journal-title":"Rep Pract Oncol Radiother"},{"issue":"1","key":"2391_CR44","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47(1):207\u201314.","journal-title":"Cancer"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02391-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-023-02391-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02391-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T18:04:24Z","timestamp":1703095464000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-023-02391-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2391"],"URL":"https:\/\/doi.org\/10.1186\/s13014-023-02391-5","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,20]]},"assertion":[{"value":"29 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of the University Medical Center G\u00f6ttingen (protocol code 19\/5\/21, date of approval: 07th June 2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"203"}}